For adults with fatty liver disease, eating all meals within an 8-hour window each day lowers systolic blood pressure more than spreading the same meals throughout the day, even when total food intake is unchanged.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether 16:8 TRE consistently reduces systolic blood pressure more than matched-calorie standard eating across diverse MASLD populations, accounting for baseline hypertension, medication use, and adherence.
A systematic review and meta-analysis of all RCTs comparing 16:8 TRE versus isocaloric standard eating in adults with MASLD and elevated BP, including at least 15 studies with 1,000+ participants total, measuring 24-hour ambulatory BP as primary outcome over 8–24 weeks.
Whether 16:8 TRE causes sustained reduction in systolic BP over 24 weeks in MASLD patients with baseline hypertension, independent of weight loss.
A multicenter, double-blind RCT of 150 adults with MASLD and baseline systolic BP ≥130 mmHg, randomized to 16:8 TRE or matched-calorie standard eating for 24 weeks, with 24-hour ambulatory BP monitoring as primary outcome, and weight change as a covariate.
Whether adults with MASLD who adopt 16:8 TRE over 5 years have a lower incidence of hypertension requiring medication compared to those who follow standard eating.
A prospective cohort study following 800 adults with MASLD for 5 years, stratified by adherence to 16:8 TRE (≥70% days), measuring annual BP trends, antihypertensive medication initiation, and cardiovascular events, adjusting for BMI, age, and baseline BP.
Whether individuals with MASLD who developed hypertension over 3 years were less likely to have practiced 16:8 TRE compared to those who remained normotensive.
A case-control study comparing 200 MASLD patients who developed hypertension within 3 years to 200 matched controls who remained normotensive, assessing prior adherence to 16:8 TRE via structured dietary recall and wearable data.
Whether adults with MASLD currently practicing 16:8 TRE have lower average systolic BP than those not practicing it, in a representative population.
A cross-sectional survey of 1,500 adults with MASLD, measuring current TRE adherence and systolic BP via standardized clinic measurement, adjusting for age, sex, BMI, and antihypertensive use.